February 13, 2025 - 14:29

WASHINGTON, D.C. — U.S. Senator Alex Padilla (D-Calif.) took to the Senate floor today to express his strong opposition to the nomination of Robert F. Kennedy Jr. as the head of the Department of Health and Human Services (HHS). Padilla highlighted significant concerns regarding the potential public health consequences should Kennedy be confirmed for the position.
In his remarks, Padilla emphasized the importance of appointing a leader at HHS who prioritizes science-based public health policies. He criticized Kennedy for his controversial views and actions, which he argued could undermine trust in health institutions at a time when the nation is still grappling with the aftermath of the COVID-19 pandemic. The senator's comments reflect a growing unease among some lawmakers about the implications of Kennedy's nomination for public health strategy and policy.
Padilla's speech underscores the critical nature of the HHS role, particularly in addressing ongoing health challenges and ensuring the safety and well-being of the American public.
November 13, 2025 - 11:51
UMass Chan Medical Students Foster Community and Health at Worcester Earn-A-BikeSecond-year medical students Hoang Vo and Diego Marroquin dedicate several hours each month to volunteering at Worcester Earn-a-Bike, a community initiative aimed at promoting health and equity...
November 12, 2025 - 20:23
Vance and Kennedy Jr. Address Public Health Strategies at MAHA SummitVice President JD Vance and Health and Human Services Secretary Robert F. Kennedy Jr. engaged in a critical dialogue regarding the Trump administration`s public health strategies during the recent...
November 12, 2025 - 08:16
Dharmendra's Health Update: Iconic Bollywood Star Discharged from HospitalDharmendra, affectionately known as the `he-man` of Bollywood, remains a beloved figure in the film industry, even at the age of 90. Recently, the veteran actor was discharged from the hospital...
November 11, 2025 - 22:23
New Weight-Loss Drug Deal Raises Concerns Over Long-Term Health RisksA recent agreement aimed at reducing the cost of popular weight-loss medications has sparked discussions about the broader implications for health. An expert from the University of Virginia...